Tag Archive
Aesthetic Dentistry
Amenorrhea
Appendectomy
Arthritis
Brain Infections
Brain Surgery
Brain Tumors
Cancer
Cerebral Palsy
Cervical Excision Procedures
Cosmetic Dentistry
Curettage
Cystoscopy
Dental Implants
Dental Surgery
Dentistry
Diagnostic Laparoscopy
Dysmenorrhoea
Endodontics
Epilepsy
Exploratory Laparotomy
Fracture
Hysterectomy
Hysteroscopy
Infertility
Ligament Tear
Menorrhagia
Muscle Injury
Neurosurgery
Oophorectomy
Oral Health
Oral Health Problems
Pediatric Dentistry
Prosthodontics
Root Canal
Spinal Cord Tumors
Sports Injuries
Stroke
Stroke Rehabilitation
Stupor
Teeth Loss
Teeth Whitening
Tooth Decay
Tubal Ligation
Urinary Infections
Neurologists in Delhi
New Delhi is the capital of India and it has the best of neurologists to treat patients suffering from neurological disorders. Neurological disorders are ailments that can affect the central nervous system (brain and spinal cord), the peripheral nervous system, or the autonomic nervous system. Neurology is the medical specialty dealing with disorders of the nervous system. Specifically, it deals with... »
Latest news on Epilepsy from Yahoo! News
- Understanding and living with epilepsy (Tri-County Times)
Few medical conditions manifest themselves more profoundly than epilepsy. A condition that produces seizures that affect a number of mental and physical functions, epilepsy affects nearly 3 million people in the United States. - Research and Markets: Target Product Profiles 2009: Physician Insights on Key Attributes: Epilepsy (Business Wire via Yahoo! Finance)
DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Target Product Profiles 2009: Physician Insights on Key Attributes: Epilepsy" to their offering. - FDA raps Medtronic device for epilepsy (Pioneer Press)
Medtronic Inc.'s deep-brain stimulation system was tied to suicides, depression and worsening seizures in a study of epilepsy patients, according to U.S. regulators weighing whether to broaden sales of the device. - (AFX UK Focus) 2010-03-10 14:48 UPDATE 1-US FDA: Medtronic missed epilepsy device study goal (Interactive Investor)
WASHINGTON, March 10 (Reuters) - Medtronic Inc missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents prepared for an advisory panel. Medtronic has applied for approval of its Deep Brain Stimulation (DBS) Therapy for patients with epilepsy. The implant is already sold for treating Parkinson's disease and ... - OSU Medical Center Unveils New Epilepsy Unit; Patients Get More Freedom (WCMH Columbus)
Epilepsy is the third leading neurological disorder in the nation. It sits right behind Alzheimer’s and stroke. This year, doctors will diagnose more than 200,000 people—and many in Central Ohio will come to The Ohio State University Medical Center’s Epilepsy Monitoring Unit. - Margaret Maye, of Epilepsy Cure Initiative Announces as Part of March Epilepsy Awareness Month, a Free Two Part Seminar (Marketwire via Yahoo! Finance)
TORONTO, ONTARIO--(Marketwire - 03/09/10) - Part One: SEMINAR FOR MEDICAL NUTRITION THERAPIES FOR THE TREATMENT OF EPILEPSY: Ketogenic Therapy in the 21st Century Sunday March 28, 2010 from 10:45 am to 3:00 pm Part Two: Cooking with KetoCal A fun presentation teaching how to prepare ketogenic meals Sunday March 28 Where: Palais Royale 1601 Lakeshore Blvd. West, Toronto www ... - Newly-Published Study Reinforces Role of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) as an Add-on Treatment that ... (redOrbit)
ATLANTA, March 11 /PRNewswire/ -- UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S. - (AFX UK Focus) 2010-03-10 17:03 UPDATE 2-FDA: Medtronic missed epilepsy device study goal (Interactive Investor)
By Lisa Richwine - FDA: Medtronic brain stimulator missed study goal (AP via Yahoo! News)
The Food and Drug Administration said Wednesday a nerve stimulating implant from Medtronic failed to significantly reduce seizures in epilepsy patients. - Summary Box: FDA Reviews Medtronic Stimulator (ABC News)
Summary Box: FDA reviewers say Medtronic missed goal in study of epilepsy treatment Medtronic - Food and Drug Administration - Health - Conditions and Diseases - Epilepsy
Epilepsy Causes, Symptoms, Diagnosis, Treatment, and Prognosis